Pharmaceutical company Pfizer has reversed its decision to cease production at one of its manufacturing plants in Co Cork, removing a threat to around 130 jobs there.
Pfizer announced in May 2013 it planned to cease production and sell the plant at Little Island within 18 months.
That deadline was then extended to autumn of this year.
However, in a statement this morning, Pfizer said manufacturing at its Little Island plant will now continue, driven by increased demand for the cholesterol-lowering drug, Atorvastatin (Lipitor).
The company said demand for Atorvastatin is projected to increase "for the foreseeable future", and it was therefore "important" to continue manufacturing at the Little Island plant.
The company said the commitment of the workforce in Little Island to factors such as cost reduction and greater competitiveness was also a factor in its decision.
It warned, however, that it will continue to review its supply needs.
Pfizer site leader at Little Island Seamus Fives said the plant's employees had demonstrated the highest levels of performance, flexibility and commitment.
Cork Chamber of Commerce has welcomed the decision.
Chief Executive Conor Healy says it offers hope of further investment by the company - a major contributor to the local economy.
But he warned that key projects such as the N28 to Ringaskiddy and the upgrade of the Dunkettle Interchange have to be prioritized in order to support regional economic growth.
Anda sedang membaca artikel tentang
Pfizer to keep manufacturing at Little Island site
Dengan url
http://newsdeadlineup.blogspot.com/2015/03/pfizer-to-keep-manufacturing-at-little.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Pfizer to keep manufacturing at Little Island site
namun jangan lupa untuk meletakkan link
Pfizer to keep manufacturing at Little Island site
sebagai sumbernya
0 komentar:
Posting Komentar